《Table 4.Primary Treatment Outcomes of RUTI Patients[Case (%) ]》

《Table 4.Primary Treatment Outcomes of RUTI Patients[Case (%) ]》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Treatment of Uncomplicated Recurrent Urinary Tract Infection with Chinese Medicine Formula: A Randomized Controlled Trial》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
Note:P<0.05 vs.CM group

The effective treatment rate with an ITT approach in which patients lost to follow-up were considered to have achieved a clinical cure was 95.1%in the antibiotics group compared to 96.7%in the CM group.The two groups showed similar primary outcomes.However，the therapeutic efficacy differed between the two groups.Approximately 30%of patients were completely clinically cured in both groups；however，the CM group showed a significantly higher rate of significant cure than the antibiotics group（47.5%vs.26.2%，P<0.05），and the antibiotics group showed a higher rate of symptomatic improvement than the CM group（39.3%vs.18.0%，P<0.05，Table 4）.

图表编号XD0049341100    严禁用于非法目的
绘制时间2019.01.01
作者LIU Shi-wei、GUO Jie、WU Wei-kang、CHEN Ze-liang、ZHANG Ning
绘制单位Department of Nephrology and Endocrinology, Wangjing Hospital, Chinese Academy of Chinese Medical Science、Department of Nephrology and Endocrinology, Wangjing Hospital, Chinese Academy of Chinese Medical Science、Institute of Integrative Medicine, Sun Yat-
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 2 Peer-reviewed literature reports on the clinical outcomes of patients undergoing endoscopic transluminal necrose》2019.04.27
  2. 《Table 2 Peer-reviewed literature reports on the clinical outcomes of patients undergoing endoscopic transluminal necrose》2019.04.27
  3. 《Table 1 Peer-reviewed literature reports on the clinical outcomes of patients undergoing percutaneous catheter drainage》2019.04.27
  4. 《Table 5.Secondary Treatment Outcomes of RUTI Patients[Case (%) ]》2019.01.01
  5. 《Table 2.Treatment, outcome and survival time of 13 induction-therapeutic patients》2019.02.20
  6. 《Table 3.Comparison of SIT between different groups of patients before and after treatment》2019.01.01
  7. 《Table 2.Comparison of BUT between different groups of patients before and after treatment》2019.01.01
  8. 《Table 5 Comparison of surgical outcomes between patients with absent and present SNAP》2019.03.01
  9. 《Table 3 Pregnancy outcomes of patients in h-FSH/n-E2and h-FSH/h-E2groupsa)》2019.01.05
  10. 《Table 1 Baseline parameters and pregnancy outcomes of patients in n-FSH and h-FSH groupsa)》2019.01.05
  11. 《Table 2 Pregnancy outcomes of patients in n-FSH/n-E2and n-FSH/h-E2groupsa)》2019.01.05
  12. 《Table 2Treatment outcomes (n=44) .》2019.02.15
  13. 《Table 1Baseline characteristics and procedural outcomes of patients who underwent EUS-TD for PCs due to AP.》2019.02.15
  14. 《Table 1:Baseline characteristics of patients receiving placebo treatment compared between Asian population and Caucasian》2018.07.05
  15. 《Table 1 Characteristics of patients reported in the literature and our case》2018.11.01
  16. 《Table 3 Surgical outcomes of patients with infantile esotropia who underwent bilateral medial rectus muscle recession be》2018.12.18
  17. 《Table 2Clinical outcomes of enrolled patients.》2018.12.15
  18. 《Table 2Surgical outcomes of patients who underwent ABO-I LDLT.》2018.04.01
  19. 《Table 3Postoperative outcomes of the study patients.》2018.02.01
  20. 《表4 两组患者末次随访时观察指标的比较Tab.4 Secondary outcomes of patients in the two groups at 6months post-treatment (Mean±SD)》2018.02.20

随机翻阅

《表2:3组患者住院时长、门诊次数对比（±s)》 《表1 输出Excel部分结果》 《表3 试样用量试验：红外吸收法与热导法同时测定铀硅化合物中氧、氮含量》 《表3 压力对过滤过程的影响》 《表7 初始干预月龄分布：75649例新生儿耳聋基因筛查及确诊者随访结果分析》 《表3《Treasures》Grade3阅读力层级及其分布状况》 《表2 锚杆挡墙计算参数：锚杆挡墙在填方路基中的应用》 《表4 参与国科学认知侧重举例》 《表1 正庚烷经催化剂催化裂解后的气相结果比较[10]》 《表4 振动信号神经网络诊断结果准确率》